The use of extracorporeal membrane oxygenation in the treatment of critical course of pneumonia.
Využití extrakorporální membránové oxygenace (ECMO) v léčbě kritického průběhu pneumonie.
COVID-19
ECMO
corticosteroid
long-term outcome
long-term results
Journal
Casopis lekaru ceskych
ISSN: 0008-7335
Titre abrégé: Cas Lek Cesk
Pays: Czech Republic
ID NLM: 0004743
Informations de publication
Date de publication:
2023
2023
Historique:
entrez:
3
3
2023
pubmed:
4
3
2023
medline:
8
3
2023
Statut:
ppublish
Résumé
Extracorporeal membrane oxygenation is the highest form of resuscitation care in management of patients with respiratory failure. In the case of acute respiratory distress syndrome, the veno-venous setting is more often used. ECMO support enables, in case of lung function failure, to obtain the necessary time for the onset of the causal treatment effect or is used as a bridge to transplantation Mortality of the patients varies according to the underlying cause and presence of risk factors (e.g., age, complications or comorbid diseases). The onset of the COVID-19 pandemic has led to a significant increase in the need for ECMO. The quality of life of patients after ECMO is significantly reduced, but most patients do not experience permanent disability.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM